会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Human selenium-binding protein
    • 人硒结合蛋白
    • US06312895B1
    • 2001-11-06
    • US09088641
    • 1998-06-02
    • Olga BandmanPhillip R. Hawkins
    • Olga BandmanPhillip R. Hawkins
    • C12Q168
    • C07K14/47A61K38/00
    • The present invention provides a human selenium-binding protein (HSEBP) and polynucleotides which identify and encode HSEBP. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding HSEBP and a method for producing HSEBP. The invention also provides for agonists and antibodies specifically binding HSEBP, and their use in the prevention and treatment of diseases associated with expression of HSEBP. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding HSEBP for the treatment of diseases associated with the expression of HSEBP. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding HSEBP.
    • 本发明提供了人类硒结合蛋白(HSEBP)和识别和编码HSEBP的多核苷酸。 本发明还提供了遗传工程改造的表达载体和宿主细胞,其包含编码HSEBP的核酸序列和生产HSEBP的方法。 本发明还提供了特异性结合HSEBP的激动剂和抗体,以及它们在预防和治疗与HSEBP表达相关的疾病中的用途。 另外,本发明提供了将反义分子用于编码HSEBP的多核苷酸用于治疗与HSEBP表达相关的疾病的用途。 本发明还提供利用多核苷酸或其片段或其互补体和特异性结合HSEBP的抗体的诊断测定法。
    • 5. 发明授权
    • Method of detecting human phospholipase inhibitor
    • 检测人磷脂酶抑制剂的方法
    • US5948626A
    • 1999-09-07
    • US153751
    • 1998-09-15
    • Phillip R. HawkinsLynn E. Murry
    • Phillip R. HawkinsLynn E. Murry
    • G01N33/53A61K31/7088A61K38/00A61K45/00A61K48/00A61P25/28C07K14/47C07K16/18C12N1/15C12N1/19C12N1/21C12N5/10C12N9/99C12N15/09C12Q1/68
    • C12Q1/6876C07K14/4703A61K38/00C12Q2600/158
    • The present invention provides a polynucleotide (gipl) the partial sequence for which was initially isolated from a THP-1 cDNA library and which identifies and encodes a novel human phospholipase inhibitor (GIPL). The invention provides for genetically engineered expression vectors and host cells comprising the nucleic acid sequence encoding GIPL. The invention also provides for the use of purified GIPL and its agonists in pharmaceutical compositions for the treatment of diseases associated with the abnormal or excess phospholipase activity. Additionally, the invention provides for the use of antisense molecules to gipl or inhibitors of GIPL in pharmaceutical compositions for the prevention of pregnancy or treatment of Alzheimer's disease. The invention also describes diagnostic assays which utilize diagnostic compositions comprising the polynucleotide, fragments or the complement thereof, which hybridize with the genomic sequence or the transcript of gipl, or anti-GIPL antibodies which specifically bind to the polypeptide, GIPL.
    • 本发明提供了一种多核苷酸(gipl),其部分序列最初从THP-1 cDNA文库中分离,并鉴定并编码新的人磷脂酶抑制剂(GIPL)。 本发明提供了包含编码GIPL的核酸序列的遗传工程表达载体和宿主细胞。 本发明还提供了纯化GIPL及其激动剂在药物组合物中用于治疗与异常或过量磷脂酶活性相关的疾病的用途。 另外,本发明提供了用于预防妊娠或治疗阿尔茨海默病的药物组合物中的GIP1或GIPL抑制剂的反义分子的用途。 本发明还描述了利用包含多核苷酸,其片段或其互补物的诊断组合物的诊断测定法,其与gipl的基因组序列或转录物或特异性结合多肽GIPL的抗GIPL抗体杂交。